121
Views
3
CrossRef citations to date
0
Altmetric
Review

Posterior scleritis

, , , &
Pages 475-484 | Received 05 Jul 2016, Accepted 18 Oct 2016, Published online: 04 Nov 2016

References

  • Benson WE. Posterior scleritis. Surv Ophthalmol. 1988;32(5):297–316.
  • Sainz De La Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119(1):43–50.
  • Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60(3):163–191.
  • Watson PG. The diagnosis and management of scleritis. Ophthalmology. 1980;87(7):716–720.
  • McGavin DD, Williamson J, Forrester JV, et al. Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol. 1976;60(3):192–226.
  • McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999;106(12):2380–2386.
  • Lavric A, Gonzalez-Lopez JJ, Majumder PD, et al. Posterior scleritis: analysis of epidemiology, clinical factors, and risk of recurrence in a cohort of 114 patients. Ocul Immunol Inflamm. 2016;24(1):6–15.
  • Cheung CM, Chee SP. Posterior scleritis in children: clinical features and treatment. Ophthalmology. 2012;119(1):59–65.
  • van der Maesen K, D’Haens EJ, van Rijn LJ, et al. Posterior scleritis in a 7-month-old infant. J Pediatr Ophthalmol Strabismus. 2007;44(6):377–378.
  • Calthorpe CM, Watson PG, McCartney AC. Posterior scleritis: a clinical and histological survey. Eye. 1988;2(Pt 3):267–277.
  • Jabs DA, Mudun A, Dunn JP, et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130(4):469–476.
  • Homayounfar G, Nardone N, Borkar DS, et al. Incidence of scleritis and episcleritis: results from the pacific ocular inflammation study. Am J Ophthalmol. 2013;156(4):752–758.
  • Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, et al. Clinical features and presentation of posterior scleritis: a report of 31 cases. Ocul Immunol Inflamm. 2014;22(3):203–207.
  • Watson PG, Young RD. Scleral structure, organisation and disease. A review. Exp Eye Res. 2004;78(3):609–623.
  • Gonzalez-Lopez JJ, Lavric A, Dutta Majumder P, et al. Bilateral posterior scleritis: analysis of 18 cases from a large Cohort of posterior scleritis. Ocul Immunol Inflamm. 2016;24(1):16–23.
  • Singh G, Guthoff R, Foster CS. Observations on long-term follow-up of posterior scleritis. Am J Ophthalmol. 1986;101(5):570–575.
  • Cleary PE, Watson PG, McGill JI, et al. Visual loss due to posterior segment disease in scleritis. Trans Ophthalmol Soc U K. 1975;95(2):297–300.
  • Benson WE, Shields JA, Tasman W, et al. Posterior scleritis. A cause of diagnostic confusion. Arch Ophthalmol. 1979;97(8):1482–1486.
  • Sears ML. Choroidal and retinal detachments associated with scleritis. Am J Ophthalmol. 1964;58:764–766.
  • Bertelsen TI. Acute sclerotenonitis and ocular myositis complicated by papillitis, retinal detachment and glaucoma. Acta Ophthalmol (Copenh). 1960;38:136–152.
  • Kouda N, Sasaki H, Harada S, et al. Early manifestation of vogt-koyanagi-harada disease as unilateral posterior scleritis. Jpn J Ophthalmol. 2002;46(5):590–593.
  • Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol. 2005;20(3):183–190.
  • Sainz de La Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101(2):389–396.
  • Sainz de La Maza M, Tauber J, Foster CS. The sclera, 2ed. New York (NY): Springer Science+Business Media, LLC; 2012.
  • Feldon SE, Sigelman J, Albert DM, et al. Clinical manifestations of brawny scleritis. Am J Ophthalmol. 1978;85(6):781–787.
  • Agrawal R, Lavric A, Restori M, et al. NODULAR POSTERIOR SCLERITIS: clinico-sonographic characteristics and proposed diagnostic criteria. Retina. 2016;36(2):392–401.
  • Goldman DR, Johnson MW, Sarraf D. Stellate neuroretinitis associated with posterior scleritis. Retin Cases Brief Rep. 2012;6(2):163–165.
  • Raiji VR, Palestine AG, Parver DL. Scleritis and systemic disease association in a community-based referral practice. Am J Ophthalmol. 2009;148(6):946–950.
  • Sainz de La Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995;102(4):687–692.
  • Shenoy R, Suryawanshi M, Isaac R, et al. Posterior scleritis in pediatric age group: a case report and review of literature. Oman J Ophthalmol. 2016;9(1):59–62.
  • Farooq O, Buccilli A, Varma C, et al. Posterior scleritis: a rare pediatric disorder. Clin Pediatr (Phila). 2009;48(8):869–872.
  • Uddin JM, Rennie CA, Moore AT. Bilateral non-specific orbital inflammation (orbital “pseudotumour”), posterior scleritis, and anterior uveitis associated with hypothyroidism in a child. Br J Ophthalmol. 2002;86(8):936.
  • Biswas J, Mittal S, Ganesh SK, et al. Posterior scleritis: clinical profile and imaging characteristics. Indian J Ophthalmol. 1998;46(4):195–202.
  • Byrne SF, Green RL. Ultrasound of the eye and orbit. Print.St Louis: Mosby Year Book; 2002.
  • Fraunfelder FT, Watson PG. Evaluation of eyes enucleated for scleritis. Br J Ophthalmol. 1976;60(3):227–230.
  • Velasco E Cruz AA, Chahud F, Feldman R, et al. Posterior scleral tuberculoma: case report. Arq Bras Oftalmol. 2011;74(1):53–54.
  • Manjunath V, Fujimoto JG, Duker JS. Cirrus HD-OCT high definition imaging is another tool available for visualization of the choroid and provides agreement with the finding that the choroidal thickness is increased in central serous chorioretinopathy in comparison to normal eyes. Retina. 2010;30(8):1320-1321;author reply 1321-1322.
  • Hirukawa K, Keino H, Watanabe T, et al. Enhanced depth imaging optical coherence tomography of the choroid in new-onset acute posterior scleritis. Graefes Arch Clin Exp Ophthalmol. 2013;251(9):2273–2275.
  • Taki W, Keino H, Watanabe T, et al. Enhanced depth imaging optical coherence tomography of the choroid in recurrent unilateral posterior scleritis. Graefes Arch Clin Exp Ophthalmol. 2013;251(3):1003–1004.
  • Auer C, Herbort CP. Indocyanine green angiographic features in posterior scleritis. Am J Ophthalmol. 1998;126(3):471–476.
  • Cordero-Coma M, Garcia-Moran A, Yilmaz T, et al. Adjunctive globe magnetic resonance imaging in the diagnosis of posterior scleritis. Can J Ophthalmol. 2011;46(4):329–332.
  • Keino H, Watanabe T, Taki W, et al. Clinical features and visual outcomes of Japanese patients with scleritis. Br J Ophthalmol. 2010;94(11):1459–1463.
  • Gupta A, Gupta V, Pandav SS, et al. Posterior scleritis associated with systemic tuberculosis. Indian J Ophthalmol. 2003;51(4):347–349.
  • Pappuru RR, Dave VP. An unusual case of ocular tuberculosis presenting as subretinal abscess with posterior scleritis. Int Ophthalmol. 2016. [Epub ahead of print].
  • Miranda AF, Cardoso J, Marques N, et al. Isolated posterior scleritis associated with tuberculosis. Arq Bras Oftalmol. 2016;79(2):111–112.
  • Tranos PG, Ong T, Nolan W, et al. Posterior scleritis presenting with annular choroidal detachment as a complication of herpes zoster ophthalmicus. Retina. 2003;23(5):716–717.
  • Krist D, Wenkel H. Posterior scleritis associated with Borrelia burgdorferi (Lyme disease) infection. Ophthalmology. 2002;109(1):143–145.
  • Taravella MJ, Johnson DW, Petty JG, et al. Infectious posterior scleritis caused by Pseudallescheria boydii. clinicopathologic findings. Ophthalmology. 1997;104(8):1312–1316.
  • Hunyor AP, Harper CA, O’Day J, et al. Ocular-central nervous system lymphoma mimicking posterior scleritis with exudative retinal detachment. Ophthalmology. 2000;107(10):1955–1959.
  • Sainz de La Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Scleritis therapy. Ophthalmology. 2012;119(1):51–58.
  • Rosenbaum JT, Robertson JE Jr. Recognition of posterior scleritis and its treatment with indomethacin. Retina. 1993;13(1):17–21.
  • Beardsley RM, Suhler EB, Rosenbaum JT, et al. Pharmacotherapy of scleritis: current paradigms and future directions. Expert Opin Pharmacother. 2013;14(4):411–424.
  • Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492–513.
  • Gangaputra S, Newcomb CW, Liesegang TL, et al. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009;116(11):2188–2198. e2181.
  • Pasadhika S, Kempen JH, Newcomb CW, et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009;148(4):500–509. e502.
  • Kacmaz RO, Kempen JH, Newcomb C, et al. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010;117(3):576–584.
  • Pujari SS, Kempen JH, Newcomb CW, et al. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. 2010;117(2):356–365.
  • Lerman MA, Burnham JM, Chang PY, et al. Response of pediatric uveitis to tumor necrosis factor-alpha inhibitors. J Rheumatol. 2013;40(8):1394–1403.
  • Durrani K, Kempen JH, Ying GS, et al. Adalimumab for ocular inflammation. Ocul Immunol Inflamm. 2016;1–8. [Epub ahead of print].
  • Ramirez-Ortiz MA, Vasquez-Resendis A. Isolated bilateral posterior scleritis after eye trauma. J Aapos. 2007;11(3):284–285.
  • Sen HN, Suhler EB, Al-Khatib SQ, et al. Mycophenolate mofetil for the treatment of scleritis. Ophthalmology. 2003;110(9):1750–1755.
  • Ozdek SC, Gurelik G, Hasanreisoglu B. An atypical posterior scleritis case: a diagnostic challenge. Retina. 2001;21(4):371–373.
  • Woon WH, Stanford MR, Graham EM. Severe idiopathic posterior scleritis in children. Eye. 1995;9(Pt 5):570–574.
  • Pagnoux C, Guillevin L. Treatment of granulomatosis with polyangiitis (Wegener’s). Expert Rev Clin Immunol. 2015;11(3):339–348.
  • Ragam A, Kolomeyer AM, Fang C, et al. Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors. Ocul Immunol Inflamm. 2014;22(6):469–477.
  • Weiss K, Rieger R, Keitzer R, et al. Successful infliximab treatment of posterior scleritis in a 13-year-old child refractory to other immunosuppressive therapy. Graefes Arch Clin Exp Ophthalmol. 2007;245(11):1735–1737.
  • Cao JH, Oray M, Cocho L, et al. Rituximab in the treatment of refractory noninfectious scleritis. Am J Ophthalmol. 2016;164:22–28.
  • Recillas-Gispert C, Serna-Ojeda JC, Flores-Suarez LF. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener’s). Graefes Arch Clin Exp Ophthalmol. 2015;253(12):2279–2284.
  • Levy-Clarke G, Jabs DA, Read RW, et al. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121(3):785–796. e783.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.